Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01877577 · ClinicalTrials.gov registry record · NA
Supplementation of Vitamin D3 in Patients With Inflammatory Bowel Diseases and Hypovitaminosis D
A NA study of Ulcerative Colitis (UC) and Crohn's Disease (CD), sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT01877577: Completed NA study of Ulcerative Colitis (UC) and Crohn's Disease (CD), sponsored by University of California, San Francisco.
NCT01877577 is a NA study of Ulcerative Colitis (UC) and Crohn's Disease (CD) that has completed, run by University of California, San Francisco. The registered enrollment target is 30 participants, below the 763-participant average among 17 other Ulcerative Colitis (UC) trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01877577, a NA study of Ulcerative Colitis (UC) and Crohn's Disease (CD), has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to evaluate the effect of vitamin D3 supplementation on disease activity and quality of life in IBD patients deficient in vitamin D, and also help determine the optimal dose of vitamin D3 for them. Hypothesis: Supplementation of vitamin D3 in IBD patients with hypovitaminosis D can improve their quality of life and decrease IBD activity.
Primary Outcome
To determine the appropriate dose of vitamin D3 supplementation in IBD patients with hypovitaminosis D.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Vitamin D3
Study Locations (1)
California
- Community Regional Medical Center, Ambulatory Care Center - Fresno
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2012-04 |
| Est. Completion | 2013-09 |
| Phase | NA |
What the finished NCT01877577 record still lists
NCT01877577 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 763-participant average among 17 other Ulcerative Colitis (UC) trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Ulcerative Colitis (UC) appearing as the primary indexed condition, and to 1 intervention - of which Vitamin D3 is the first listed.
NCT01877577 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01877577 about?
NCT01877577 is a clinical study titled "Supplementation of Vitamin D3 in Patients With Inflammatory Bowel Diseases and Hypovitaminosis D". This study aims to evaluate the effect of vitamin D3 supplementation on disease activity and quality of life in IBD patients deficient in vitamin D, and also help determine the optimal dose of vitamin D3 for them. Hypothesis: Supplementation of vitamin D3 in IBD patients with hypovitaminosis D can ...
What is the current status of trial NCT01877577?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2012-04. Estimated completion is 2013-09.
What conditions does trial NCT01877577 study?
This clinical trial studies the following conditions: Ulcerative Colitis (UC), Crohn's Disease (CD).
What interventions are being tested in trial NCT01877577?
The interventions under investigation include: Vitamin D3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01877577?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01877577 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ulcerative Colitis (UC)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01877577's enrollment target sits among peer trials
30 16th of 17 higher than 2 of 17 other Ulcerative Colitis (UC) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ulcerative Colitis (UC) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission
RECRUITING · NA
-
Evaluation of the SMART IBD App in Pediatric IBD
RECRUITING · NA
-
Use of Psychologist-administered Cognitive Behavioral Therapy (CBT) or Self-administered CBT for the Treatment of Anxiety and/or Depression in Inflammatory Bowel Disease (IBD)
RECRUITING · NA
-
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
RECRUITING
-
Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
RECRUITING · Phase 2
-
Evaluate the Safety, Tolerability, PK and PD of SAD of Intravenously Adminsterted ALTB-268 in Healthy Participants
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia